• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NT-proBNP:心脏疾病的重要生物标志物。

NTproBNP: an important biomarker in cardiac diseases.

机构信息

Cardiology Department and Cardiac Catheterization Laboratory, Athens General Hospital G.Gennimatas, Athens, Greece.

出版信息

Curr Top Med Chem. 2013;13(2):82-94. doi: 10.2174/1568026611313020002.

DOI:10.2174/1568026611313020002
PMID:23470072
Abstract

Natriuretic neuropeptides (ANP, BNP, CNP) are produced primarily in the cardiac atria under normal conditions. The main stimulus for ANP and BNP peptide synthesis and secretion is cardiac wall stress. Cardiac ventricular myocytes constitute the major source of BNP-related peptides. Ventricular NT-proBNP production is upregulated in cardiac failure and locally in the area surrounding a myocardial infarct. NT-proBNP is cleared passively by organs with high rate of blood flow (muscle, liver, kidney). It has a longer half life than BNP and higher plasma concentration. BNP and NTproBNP tend to be higher in women and lower in obese individuals. They are also higher in elderly, in left ventricular tachycardia, right ventricular overload, myocardial ischemia, hypoxaemia, renal dysfunction, liver cirrhosis, sepsis and infection. NT-proBNP is useful both in the diagnosis and prognosis of heart failure and is considered to be a gold standard biomarker in heart failure similar to BNP. A cut-off point 300 pg/ml has 99% sensitivity, 60%specificity and NPV 98%for exclusion of acute heart failure. NT proBNP has also a strong prognostic value of death in acute and chronic heart failure and also predicts short and long term mortality in patient with suspected or confirmed unstable CVD. Natriuretic peptides are also prognostic markers for the RV (Right Ventricular) Dysfunction. Their release is due to myocardial stretch from right ventricular pressure overload.Finally, there are data supporting that NT-proBNP might be useful to put a time frame on atrial fibrillation of unknown onset.

摘要

利钠肽(ANP、BNP、CNP)主要在正常情况下由心房产生。ANP 和 BNP 肽合成和分泌的主要刺激因素是心脏壁张力。心室心肌细胞构成 BNP 相关肽的主要来源。心力衰竭和心肌梗死周围区域局部会导致心室 NT-proBNP 产生增加。NT-proBNP 可被血流速度高的器官(肌肉、肝脏、肾脏)被动清除。它的半衰期比 BNP 长,血浆浓度更高。BNP 和 NT-proBNP 在女性中较高,在肥胖个体中较低。在老年人、左室性心动过速、右室超负荷、心肌缺血、低氧血症、肾功能不全、肝硬化、败血症和感染中也更高。NT-proBNP 在心衰的诊断和预后中都很有用,被认为是心衰的金标准生物标志物,与 BNP 相似。截断值 300 pg/ml 对急性心衰的排除具有 99%的敏感性、60%的特异性和 98%的阴性预测值。NT proBNP 在急性和慢性心衰中也具有很强的死亡预后价值,并且还可以预测疑似或确诊不稳定 CVD 患者的短期和长期死亡率。利钠肽也是右心室(RV)功能障碍的预后标志物。它们的释放是由于右心室压力超负荷导致的心肌拉伸。最后,有数据支持 NT-proBNP 可能有助于确定不明原因心房颤动的时间框架。

相似文献

1
NTproBNP: an important biomarker in cardiac diseases.NT-proBNP:心脏疾病的重要生物标志物。
Curr Top Med Chem. 2013;13(2):82-94. doi: 10.2174/1568026611313020002.
2
[Diagnostic value of the currently used criteria and brain natriuretic peptide for diagnosing congestive heart failure in children with congenital heart disease].[目前使用的标准及脑钠肽对先天性心脏病患儿充血性心力衰竭的诊断价值]
Zhonghua Er Ke Za Zhi. 2006 Oct;44(10):728-32.
3
Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.代偿性肾功能不全对已批准的心力衰竭标志物的影响:脑钠肽(BNP)与N末端脑钠肽原(NT-proBNP)的直接比较
Hypertension. 2005 Jul;46(1):118-23. doi: 10.1161/01.HYP.0000170140.36633.8f. Epub 2005 Jun 6.
4
BNP as a biomarker in heart disease.B型利钠肽作为心脏病的生物标志物。
Adv Clin Chem. 2005;40:1-36.
5
B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.B型利钠肽(BNP)和N末端前脑钠肽原用于休克或急性呼吸窘迫时心力衰竭的诊断。
Acta Anaesthesiol Scand. 2006 Mar;50(3):340-7. doi: 10.1111/j.1399-6576.2006.00963.x.
6
Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major.B 型利钠肽在检测β-地中海贫血症患者隐匿性左心室舒张功能障碍中的预测价值。
Am Heart J. 2010 Jan;159(1):68-74. doi: 10.1016/j.ahj.2009.10.025.
7
Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.慢性心力衰竭患者经心脏脑钠肽(BNP)和N末端脑钠肽原增加的直接比较及其预后
Circ J. 2007 Dec;71(12):1873-8. doi: 10.1253/circj.71.1873.
8
Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload.羊血浆中的氨基末端脑钠肽原:应对心脏负荷过重时分泌增强的证据。
Am J Physiol. 1998 Oct;275(4):H1200-8. doi: 10.1152/ajpheart.1998.275.4.H1200.
9
Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?三种利钠肽在血液透析患者中的诊断性能比较:哪种是合适的生物标志物?
Kidney Blood Press Res. 2012;36(1):172-81. doi: 10.1159/000343406. Epub 2012 Oct 30.
10
Comparative value of BNP and NT-proBNP in diagnosis of heart failure.BNP与NT-proBNP在心力衰竭诊断中的比较价值
Rev Port Cardiol. 2004 Jul-Aug;23(7-8):979-91.

引用本文的文献

1
Deferral of scheduled transcatheter heart valve interventions strongly increases the risk of congestive heart failure.推迟预定的经导管心脏瓣膜介入治疗会显著增加充血性心力衰竭的风险。
Sci Rep. 2025 Sep 1;15(1):32151. doi: 10.1038/s41598-025-16742-7.
2
Evaluation of Altered Myocardial Blood Flow and Cardiovascular Function in Patients With Thyroid Cancer and Related Treatments.甲状腺癌患者及其相关治疗中改变的心肌血流和心血管功能评估
In Vivo. 2025 Sep-Oct;39(5):2919-2930. doi: 10.21873/invivo.14092.
3
Association Between Levels of N-Terminal Pro-brain Natriuretic Peptide and Coronary Artery Lesion in Patients with Kawasaki Disease: A Systematic Review and Meta-analysis.
川崎病患者N末端脑钠肽前体水平与冠状动脉病变的关联:一项系统评价和荟萃分析
Arch Rheumatol. 2025 Jun 23;40(2):256-266. doi: 10.5152/ArchRheumatol.2025.11128.
4
Prediction of 28-day mortality in patients with sepsis based on a predictive model: A retrospective cohort study.基于预测模型的脓毒症患者28天死亡率预测:一项回顾性队列研究。
J Int Med Res. 2025 Aug;53(8):3000605251361104. doi: 10.1177/03000605251361104. Epub 2025 Jul 31.
5
Right ventricular function in pulmonary hypertension and obesity: a cross-sectional cohort study with survival follow-up.肺动脉高压与肥胖患者的右心室功能:一项具有生存随访的横断面队列研究
Clin Res Cardiol. 2025 Jun 24. doi: 10.1007/s00392-025-02682-9.
6
Dapagliflozin improves cardiac function and reduces adverse events in myocardial infarction: a meta-analysis in diabetic and non-diabetic populations.达格列净改善心肌梗死后的心功能并减少不良事件:糖尿病和非糖尿病人群的荟萃分析
Front Endocrinol (Lausanne). 2025 Jun 4;16:1594861. doi: 10.3389/fendo.2025.1594861. eCollection 2025.
7
Identification of biomarkers and immune microenvironment associated with heart failure through bioinformatics and machine learning.通过生物信息学和机器学习识别与心力衰竭相关的生物标志物和免疫微环境。
Front Mol Biosci. 2025 May 8;12:1580880. doi: 10.3389/fmolb.2025.1580880. eCollection 2025.
8
Platelet transfusion induces transfusion-associated circulatory overload in rats with myocardial infarction.血小板输注可诱发心肌梗死大鼠发生输血相关循环超负荷。
Transfusion. 2025 Jul;65(7):1251-1263. doi: 10.1111/trf.18285. Epub 2025 May 19.
9
Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease.NT-proBNP、MPO和NLR联合超声心动图在老年瓣膜性心脏病患者恶性心律失常预测中的临床价值
Perioper Med (Lond). 2025 Apr 22;14(1):44. doi: 10.1186/s13741-025-00527-7.
10
Development and validation of a machine learning model for online predicting the risk of in heart failure: based on the routine blood test and their derived parameters.基于常规血液检测及其衍生参数的在线预测心力衰竭风险的机器学习模型的开发与验证
Front Cardiovasc Med. 2025 Mar 17;12:1539966. doi: 10.3389/fcvm.2025.1539966. eCollection 2025.